Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)
Claude Preudhomme(Centre Hospitalier Universitaire de Lille), Hervé Dombret(Université Paris Cité), Stéphane de Botton(Université Paris-Saclay), Charlotte Lamandin(Inserm), Emmanuel Raffoux(Inserm), Xavier Thomas(Hôpital Lyon Sud), Nicolas Boissel(Inserm), Isabelle Tigaud(Inserm), C. Sagot(Inserm), Sylvie Castaigné(Hôpital André Mignot), Jean‐Michel Cayuela(Inserm), Pierre Fenaux(Saint Louis University Hospital)
Cited by 503
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k